Insights from a December 2025 Harm Reduction Journal study

A multidisciplinary panel of U.S. researchers, clinicians, and people with lived experience of substance use recently published a powerful analysis in the Harm Reduction Journal showing that the rescheduling of cannabis was a necessary move.  

What the Study Did

Instead of relying on assumptions or outdated legal categories, the team used a structured tool called multi-criteria decision analysis to evaluate 19 commonly used substances across 18 dimensions of harm, everything from overdose risk and long-term health effects to social and economic impact.

Seventeen experts, including scientists, clinicians, and people with lived experience, scored and weighted each drug, producing a risk ranking grounded in evidence rather than politics.

Why This Matters for Health and Policy

The study underscores a simple but uncomfortable truth: punitive drug laws are not grounded in science, and they aren’t reducing harm. Instead, they contribute to stigma, criminalization, and barriers to care.

By contrast, the authors argue for evidence-based scheduling and harm-reduction approaches policies informed by real risk assessments, focused on health, wellness, and quality of life rather than punishment.

Big Picture Takeaway

Federal Drug Policy vs. Science: What a New Study Reveals About Harm Reduction and Public Health

Published: December 2025 | Source: Harm Reduction Journal

For decades, U.S. drug policy has been shaped more by politics than science. A new peer-reviewed study published in the December 2025 issue of the Harm Reduction Journal confirms what many healthcare professionals and researchers have long suspected: federal drug scheduling was poorly aligned with scientific evidence and real-world risk.

The findings add critical momentum to ongoing conversations about drug reform, cannabis policy, and harm-reduction-based approaches to public health, along with the recent rescheduling of cannabis signed into law last year.

What the Study Examined

The study brought together a multidisciplinary panel of researchers, clinicians, and individuals with lived experience of substance use to evaluate how harmful various drugs actually are, not how they’re legally categorized.

Using a multi-criteria decision analysis model, researchers assessed 19 commonly used substances across 18 categories of harm, including:

• Risk of overdose
• Long-term health effects
• Addiction potential
• Social and economic harm
• Impact on families and communities

This approach moves beyond stigma and looks at measurable, evidence-based outcomes.

Key Findings: Policy and Science Don’t Match

1. Cannabis Is Over-Penalized Compared to Higher-Risk Substances

Researchers found that cannabis consistently ranked lower in harm than many substances that are legally prescribed or less restricted, yet it remained federally classified alongside drugs deemed to have “no accepted medical use” until recently.

Meanwhile, substances with significantly higher overdose risk and social harm often face fewer regulatory barriers.

3. Most Drug-Related Harm Affects the Individual, Not Society

Contrary to political narratives that frame drug use as a public safety crisis, the study found that:

• The majority of harm occurs at the individual health level
• Social harm is often tied to criminalization, stigma, and lack of access to care
• Punitive policies increase risk rather than reduce it

This reinforces the growing consensus that drug use should be treated as a public health issue, not a criminal one.

Why This Matters for Cannabis, Wellness & Harm Reduction

At True Harmony, we believe wellness begins with evidence-based decision-making, transparency, and respect for the plant and the people who use it.

This research supports several core principles:

✔️ Science should guide policy
✔️ Harm reduction saves lives
✔️ Access to regulated, tested cannabis improves safety
✔️ Education works better than punishment

As more states modernize cannabis laws and prioritize consumer safety, studies like this provide the scientific backbone needed to move federal policy forward.

The Bigger Picture: Toward Smarter Drug Policy

The study’s authors ultimately call for:

• Drug scheduling based on scientific risk assessment
• Expanded harm reduction strategies
• Reduced stigma surrounding substance use
• Policies rooted in public health, not fear

In short: better data leads to better outcomes, for individuals, families, and communities alike.

Final Thought

When science leads, people benefit. And when policy catches up with evidence, we create safer, more compassionate systems that actually work.

At True Harmony, we’re proud to support education, transparency, and thoughtful conversations around cannabis, wellness, and responsible reform.